Related Experiment Video
Updated: Jun 17, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Prenatal hair development: implications for drug exposure determination
1Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada. joey.gareri@sickkids.ca
Abstract:
Neonatal hair is a clinically important toxicological matrix, as it allows determination of in utero drug exposure. This paper serves to review the physiological development of the hair follicle and hair production during fetal life. An understanding of the mechanisms and timing of hair development in the prenatal period is critical to effectively assessing the time window of exposure determination associated with toxicological analysis of neonatal hair.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Teratogenicity
Drug Toxicity: Dose-Dependent Reactions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Excretion: Miscellaneous Routes
Factors Affecting Drug Response: Overview

